ARATANA THERAPEUTICS, INC. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$35.4M

Net Income/Loss (FY2018)

-$14.7M

Total Assets (FY2018)

$106.4M

Total Equity (FY2018)

$100.8M

Cash Flows from Operating Activities (FY2018)

-$11.3M

Source: ARATANA THERAPEUTICS, INC. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.